Resumen

TABAKOV, A.; GARCIA LUQUE, A.; SANCHEZ LOPEZ, P.  y  CABANES MARISCAL, M.A.. Positive assessment of drugs: March, April and May 2014. Sanid. Mil. [online]. 2014, vol.70, n.3, pp.191-196. ISSN 1887-8571.  https://dx.doi.org/10.4321/S1887-85712014000300009.

The drugs assessed by the Spanish Agency for Medicines and Health Products made public in April, May and June of 2014, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palabras clave : Acido Folico; Neocepri^®; Ataluren; Translarna^®; Brinzolamida; Brimonidina Tartrato; Simbrinza^®; Empagliflozina; Jardiance^®; Etarfolatida; Folcepri^®; Obinutuzumab; Gazyvaro^®; Peginterferon Beta-1^a; Plegridy^®; Siltuximab; Sylvant^®; Simeprevir; Olysio^®; Simoctocog Alfa; Nuwiq^®; Tacrolimus; Envarsus^®; Trametinib; Mekinist^®; Vedolizumab; Entyvio^®; Vintafolida; Vynfinit^®.

        · resumen en Español     · texto en Español     · Español ( pdf )